AzTrials
AzTrials

Pulp NecrosisNCT03717337

Success Rate of Single Versus Two Visit Regenerative Treatment Protocol in Non Vital Mature Anterior Teeth

A study testing Single visit pulp regeneration and Two visit pulp regeneration in people with Pulp Necrosis and Periapical Lesion, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study evaluates success rate of non vital mature anterior teeth with periapical lesion treated by regenerative endodontic protocol in single visit versus two visit technique. Read more about this study

Who is it for?
Ages 15 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Pulp Necrosis, Periapical Lesion, Anterior Teeth
What is being tested?
Single visit pulp regeneration and Two visit pulp regeneration
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
1 Jan 2019to 1 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Single canal anterior tooth
  • Mature root
  • Non vital with radiographic evidence of periapical lesion
  • Periapical lesion of average size 2-5mm
  • Positive patient compliance for participation in the study.
  • Patients with good oral hygiene
  • Normal periodontal probing depth ≤ 3 mm

Who cannot join

  • Compromised remaining tooth structure that need post and core build up
  • Non restorable teeth
  • Vital teeth
  • Radiographic evidence of external or internal root resorption.
  • Roots showing fracture or ankylosis
  • Medically compromised patients
Show all 10Show fewer
  • Pregnant women
  • Greater than grade I mobility or periodontal probing depth greater than 3mm
  • Immature tooth
  • Patients with pain, swelling or fistula tracts

About this study

Official title: Evaluation of Success Rate of Non Vital Mature Anterior Teeth With Periapical Lesion Following Single Versus Two Visit Regenerative Treatment Protocol A Randomized Clinical Study

This study evaluates success rate of non vital mature anterior teeth with periapical lesion treated by regenerative endodontic protocol in single visit versus two visit technique.

Patients are randomized into two groups where treatment will be done either in one visit including access, disinfection, placing platelet rich plasma as scaffold and restoration or two visit protocol involving access, disinfection and placing calcium hydroxide as intracanal medicament in first visit followed by a second visit after 3 weeks involving reopening of the tooth, removing intracanal medicament and placing platelet rich plasma as scaffold then restoration. Success rate is defined as absence of subjective signs and symptoms along with healing of periapical lesion

Read the detailed description

Title: Evaluation of Success Rate of Non Vital Mature Anterior Teeth with Periapical Lesion Following Single versus Two Visit Regenerative Treatment Protocol (A Randomized Clinical Trial) Regenerative endodontics can be defined as biologically based procedures designed to replace damaged structures, including dentin and root structures, as well as cells of the pulp-dentin complex.

The majority of endodontic patients are adults, thus the application of the tissue engineering concept to mature teeth could provide a biological treatment modality instead of the conventional one. In fact, several advantages were reported about regenerative procedures in well developed mature teeth. Reconstitution of the neurovascular system in root canals by pulp regeneration will provide pulp tissues with an immune system, which will function as the first line of defense against microbial challenge. Moreover, restoration of pulp dentine complex will protect the tooth during loading and mastication.

Different treatment protocols for pulp regeneration were reported in the literature regarding irrigation (type, concentration and time), intracanal medication, pulpal space barrier, incorporation and lack of scaffolds (blood clot, PRP,PRF, collagen) as well as recall visits.

Rationale for conducting the research and choice of comparators:

Multiple visits protocol has been the commonly used technique in regenerative endodontic procedures. It involves the placement of intracanal medicaments between visits (calcium hydroxide and triple antibiotic paste) which have many drawbacks such as difficulty in removal, tooth discoloration, weakening of the root and tooth loss.

Completing revascularization in one visit has many advantages. First, it reduces the chance of additional bacterial contamination of the space. Second, a single revascularization protocol may overcome the problem of poor patient compliance and reduce the number of appointments needed. Third, it can help to combat potential injury of the tooth and tooth discoloration Unfortunately, up till the moment it is not clear which protocol is the most effective. Thus randomized clinical trials are required to provide plausible answers to this question In the present research the recent single visit regenerative treatment for necrotic mature teeth will be compared to the conventionally used two visit one

Being tested
Single visit pulp regeneration, Two visit pulp regeneration
Keywords
Regeneration, mature teeth, regenerative procedures
Medical subject headings
Dental Pulp Necrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Single visit pulp regenerationProcedure or surgery

    Access cavity, disinfection, preparing and injecting platelet rich plasma, and restoring the tooth all done in one visit.

  • Two visit pulp regenerationProcedure or surgery

    first visit : access, disinfection and placing calcium hydroxide as intracanal medicament second visit: re opening of tooth, preparing and injecting platelet rich plasma and restoring the tooth.

Study groups in NCT03717337
Study groupRoleWhat they receive
Single visit pulp regenerationExperimentalRegenerative endodontic procedure not involving placement of intracanal medicament will be done in single visit
Receives: Procedure: Single visit pulp regeneration
Two visit pulp regenerationActive comparatorRegenerative endodontic procedure involving placing intracanal medicament will be done in two visit
Receives: Procedure: Two visit pulp regeneration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Post operative pain: NRS

    absence of pain reported by the patient by numerical rate scale, the 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")

    Measured: 3, 6, 9 and 12 months

  2. Change in swelling and/or sinus

    The presence of swelling or sinus will be reported by a binary question yes/no

    Measured: 3,6,9,12 months

  3. Periapical healing

    The existing periapical lesion will be measured by mm by CBCT before intiation of treatment and after one year

    Measured: 12 months

Secondary outcomes (3)
  1. Antimicrobial effect

    intracanal bacterial count by culture method

    Measured: before and after complete disinfection either in the same visit or after 3 weeks from the second visit

  2. Sensitivity

    Tooth giving respond to electrical pulp tester

    Measured: 3, 6, 9 and 12 months

  3. Discoloration

    Recording tooth shade before and after treatment

    Measured: 3, 6, 9 and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Oct 2018
  2. Study start1 Jan 2019 (estimated)
  3. Primary completion1 Sep 2020 (estimated)
  4. Study completion1 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The design of this randomized clinical trial is a parallel group two arms trial with 1:1 allocation ratio
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03717337
Sponsor's protocol ID
Faculty of dentistry 2018
Status last verified
Oct 2018
First submitted
14 Oct 2018
Last updated
24 Oct 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Lasheen LR, Gawdat SI, Lutfy RA. Success Rate of Single Versus Two-Visit Regenerative Treatment Protocol in Non-Vital Mature Anterior Teeth (A Preliminary Randomised Clinical Trial). Aust Endod J. 2025 Aug;51(2):308-316. doi: 10.1111/aej.12943. Epub 2025 Apr 11.

    PubMed 40219648

Questions about this trial

What is this clinical trial studying?

A study testing Single visit pulp regeneration and Two visit pulp regeneration in people with Pulp Necrosis and Periapical Lesion, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Post operative pain: NRS (time frame: 3, 6, 9 and 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03717337, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in